(Press-News.org) The paper, “Understanding low bivalent COVID-19 booster uptake among US adults,” was published in the journal Vaccine.
“Our results indicate that we have a lot more work to do in terms of educating the public and health care providers about the importance of staying up to date on COVID-19 boosters,” said first author Elizabeth Jacobs, PhD, professor of epidemiology at the Zuckerman College of Public Health, who led the research with associate professor of epidemiology Kristen Pogreba-Brown, PhD, MPH.
Nearly 40% of survey participants reported they did not get a booster shot because of a prior infection with SARS-CoV-2, the virus that causes COVID-19.
The second-most common reason was concern about vaccine side effects (31.5%), followed by believing that the booster would not provide additional protection over the vaccines already received (28.6%) or that it would not protect from SARS-CoV-2 infection (23.1%).
Some of the answers provided differed by characteristics such as age, ethnicity and education, suggesting that a variety of strategies may be needed to improve vaccination rates.
This project was conducted through Arizona CoVHORT, a longitudinal study launched in May 2020 that tracks the acute and long-term impacts of SARS-CoV-2 infection among Arizonans. The researchers sent a questionnaire to CoVHORT participants asking if they had gotten the booster and, if not, to select the reason or reasons for not having done so.
As the next COVID-19 booster rolls out this fall, the investigators hope the results can help design interventions to ensure that more people are protected from the latest SARS-CoV-2 variants.
“Our results indicate that many people don’t know that a booster provides additional protection even if they have already been infected or that the effectiveness of prior boosters wanes over time due to new variants,” Jacobs said. “So it’s important to get another booster as we head into the fall and winter.”
The Arizona CoVHORT study is continuing to enroll participants in conjunction with a grant from the Centers for Disease Control and Prevention to study the prevalence and symptoms of long COVID.
END
Study uncovers reasons Americans did not get booster vaccines
More than 80% of the people who were eligible to receive a COVID-19 booster last fall did not. New research is identifying the reasons why.
2023-10-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Texas engineers land semiconductor grants through CHIPS Act-backed NSF program
2023-10-03
A pair of Cockrell School research teams are part of a massive semiconductor grant program from the National Science Foundation that includes funds from industry leaders and the federal CHIPS Act.
The projects are part of the NSF Future of Semiconductors (FuSe) program through a public-private partnership between NSF and four major tech companies: Ericsson, IBM, Intel and Samsung. FuSe aims to enable rapid progress in new semiconductor technologies and manufacturing as well as workforce development.
Altogether, the program will support 24 research and ...
Gut bacteria found in wild wolves may be key to improving domestic dogs’ health
2023-10-03
BEND, Ore. – Gut microbes found in wild wolves may be the key to alleviating a debilitating gastrointestinal condition common to domestic dogs, according to a study led by researchers at Oregon State University – Cascades.
In a paper published in Applied Microbiology, the authors report a novel strain of Paenibacillus bacteria with characteristics of a probiotic – an organism that conveys a health benefit to the host.
In this case, the benefit would be to head off canine inflammatory ...
Host genetics helps explain childhood cancer survivors’ mortality risk from second cancers
2023-10-03
(MEMPHIS, Tenn. – October 02, 2023) The population of childhood cancer survivors in the U.S. is increasing, with an overall childhood cancer survival rate greater than 85% five years after diagnosis. However, survivors can still be at increased risk of various health conditions, including second cancers. Using data from the Childhood Cancer Survivor Study (CCSS) and the St. Jude Lifetime Cohort Study (St. Jude Life), scientists at St. Jude Children’s Research Hospital have identified a genetic ...
How floods kill, long after the water has gone – global decade-long study
2023-10-03
With New York declared a state of emergency following flash flooding, there is increasing concern such events will become more common globally.
Now a study led by Monash University scientists in Australia has found that people impacted by a flooding event are at significantly increased risk of dying – including heart and lung problems – in a crucial window between three and six weeks after the event, even after the flooding has dissipated.
The study, published today in the BMJ, found that the risk of dying increased and persisted for up to 60 days (50 days for cardiovascular mortality) after a flooded day - increasing by for 2.1% for all-cause deaths, 2.6% for cardiovascular ...
USC joins LA-area stem cell institutes in forming a regenerative medicine consortium
2023-10-03
USC is partnering with seven of Los Angeles’ leading regenerative medicine institutes to form the Los Angeles and surrounding area regenerative medicine consortium (LA-RMC), with the goal of fulfilling the promise of the California Institute for Regenerative Medicine (CIRM): to develop laboratory discoveries into treatments for patients with unmet medical needs.
CIRM, the voter-created agency that provides public funding for stem cell research in California, is dedicated to advancing regenerative medicine, which uses stem cells and related approaches to treat disease and disorders. Regenerative ...
When cells go boom: study reveals inflammation-causing gene carried by millions
2023-10-03
Australian researchers at WEHI have found that a genetic change that increases the risk of inflammation, through a process described as ‘explosive’ cell death, is carried by up to 3% of the global population.
The study may explain why some people have an increased chance of developing conditions like inflammatory bowel disease or suffer more severe reactions to infections with bacteria like Salmonella.
At a glance
MLKL is a gene essential to triggering necroptotic cell death – a natural process that protects our body from infection. In some people this process can go awry and ...
Study from Fukushima shows even low doses of radiation may contribute to diabetes
2023-10-03
New research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), suggests that exposure to low doses of radiation may contribute to an increased risk of diabetes.
The study by Dr Huan Hu and Dr Toshiteru Ohkubo from the Japanese National Institute of Occupational Safety and Health involved more than 6,000 out of around 20,000 emergency workers who responded to the radiation accident at the Fukushima Daiichi Nuclear Power Plant, which was hit by a huge tsunami in March 2011.
Substantial amounts of radioactive materials were released into the environment following explosions at the ...
Worldwide audit finds testosterone replacement improves blood sugar control in men with type 2 diabetes
2023-10-03
Real-world data from an ongoing international audit of testosterone deficiency in men with type 2 diabetes, being presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), suggests that testosterone replacement therapy (TRT) improves glycaemic control for up to 2 years.
The early data from 37 centres across 8 countries who have so far joined the Association of British Clinical Diabetologists (ABCD) audit [1], suggest that the reason that HbA1c (a measure of average blood sugar levels over the past 2-3 months) continues ...
Semaglutide significantly improves blood sugar control and weight loss in adults with type 2 diabetes for up to 3 years in real-world study
2023-10-03
New research presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), shows that treatment with the drug semaglutide significantly improves blood sugar control and weight loss in adults with type 2 diabetes for up to three years.
“Our long-term analysis of semaglutide in a large and diverse cohort of patients with type 2 diabetes found a clinically relevant improvement in blood sugar control and weight loss after 6 months of treatment, comparable with that seen in randomised trials”, says Professor Avraham Karasik from the Institute of Research and Innovation at Maccabi Health Services ...
Drinking dark tea every day may help control blood sugar to reduce diabetes risk
2023-10-03
Drinking dark tea every day may help to mitigate type 2 diabetes risk and progression in adults through better blood sugar control, suggests new research at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct).
The study, by researchers from the University of Adelaide in Australia and Southeast University in China, found that compared with never tea drinkers, daily consumers of dark tea had 53% lower risk for prediabetes and 47% reduced risk for type 2 diabetes, even after taking into account established risk factors known to drive the risk for diabetes, including age, ...
LAST 30 PRESS RELEASES:
Protein shakeup: Researchers uncover new function of a protein that may unlock age-related illnesses
UMD-led study could ‘pave the way’ for improved treatment of premature aging disease
How chain IVF clinics improve infertility treatment
Study shows that Rett syndrome in females is not just less severe, but different
Big data, real world, multi-state study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death
Manliness concerns impede forgiveness of coworkers
Better ocean connectivity boosts reef fish populations
Two 2024 Nobel laureates are affiliates of the Marine Biological Laboratory, Woods Hole
Ultra-processed foods pose unique dangers for people with type 2 diabetes
When hurricanes hit, online chatter drowns out safety messaging
Study seeks rapid, paper-based test to detect cancer cells in cerebrospinal fluid
Raising happy eaters: Unlocking the secrets of childhood appetite
The Society of Thoracic Surgeons launches two new thoracic surgery risk calculators
FAPESP and CNR plan to launch joint call for proposals in April 2025
Smaller, more specific academic journals have more sway over policy
Medicaid ACOs have not yet improved care for kids with asthma
New study sheds light on lily toxicity in cats; outpatient treatment may be viable option
A new benchmark to recognize the hardest problems in materials science
Why do we love carbs? The origins predate agriculture and maybe even our split from Neanderthals
Key protein for the biosynthesis of defense steroids in solanaceous plants discovered
Global CO2 emissions from forest fires increase by 60%
AI-assisted deliberation can help people with different views find common ground
Special Issue explores factors influencing democratic attitudes, and what’s at stake for science in the U.S. after November election
Extratropical forest fire emissions are increasing as climate changes
A new approach to capturing complex mixtures of organic chemicals in blood, evaluated in pregnant women
Gut instincts: Intestinal nutrient sensors
Catching prey with grappling hooks and cannons
Effects of chemical mixtures: Neurotoxic effects add up
Mpox in Africa was neglected during the previous outbreak, and requires urgent action and investment by leaders now to prevent global spread
A new era of treating neurological diseases at the blood-brain-immune interface
[Press-News.org] Study uncovers reasons Americans did not get booster vaccinesMore than 80% of the people who were eligible to receive a COVID-19 booster last fall did not. New research is identifying the reasons why.